CRSP vs XLI
Crispr Therapeutics AG (CRSP) versus XLI (XLI) — a side-by-side from cached financials, not a winner call.
Crispr Therapeutics AG (CRSP) is a biotechnology company listed on US.
XLI (XLI) common stock.
Latest reported CRSP revenue for 2026-06-30 was $11.6M. Net income was -$214.1M. CRSP currently screens at market cap $5.42B.
XLI does not have a complete income-statement cache yet.
CRSP currently screens at market cap $5.42B. XLI currently screens at market cap $0.
Not investment advice. Open the CRSP and XLI stock pages for the full models.
Not investment advice.